¿Es posible una nueva era en el manejo del asma?

205 Rikkers-Mutsaerts ER, Winters AE, Bakker MJ, et al, and the SMASHING Study Group. Internet-based self-management compared with usual care in adolescents with asthma: a randomized controlled trial. Pediatr Pulmonol 2012; 47: 1170–79.

206 van Nimwegen FA, Penders J, Stobberingh EE, et al. Mode and place of delivery, gastrointestinal microbiota, and their influence on asthma and atopy. J Allergy Clin Immunol 2011; 128: 948–55.

207 von Mutius E. Childhood experiences take away your breath as a young adult. Am J Respir Crit Care Med 2002; 165: 1467–68.

 208 Loss GJ, Depner M, Hose AJ, et al, and the PASTURE (Protection against Allergy Study in Rural Environments) Study Group. The Early Development of Wheeze. Environmental Determinants and Genetic Susceptibility at 17q21. Am J Respir Crit Care Med 2016; 193: 889–97.

209 Pekkanen J, Hyvarinen A, Haverinen-Shaughnessy U, Korppi M, Putus T, Nevalainen A. Moisture damage and childhood asthma: a population-based incident case-control study. Eur Respir J 2007; 29: 509–15.

210 Jensen ME, Wood LG, Gibson PG. Obesity and childhood asthma—mechanisms and manifestations. Curr Opin Allergy Clin Immunol 2012; 12: 186–92.

211 Salam MT, Li YF, Langholz B, Gilliland FD, and the Children’s HealthStudy. Early-life environmental risk factors for asthma: findings from the Children’s Health Study. Environ Health Perspect 2004; 112: 760–65.

212 Al-Sahab B, Hamadeh MJ, Ardern CI, Tamim H. Early menarche predicts incidence of asthma in early adulthood. Am J Epidemiol 2011;173: 64–70.

213 McGeachie MJ, Yates KP, Zhou X, et al, and the CAMP ResearchGroup. Patterns of Growth and Decline in Lung Function in Persistent Childhood Asthma. N Engl J Med 2016; 374: 1842–52.

214 Calverley PM, Anderson JA, Celli B, et al, and the TORCH investigators. Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease. N Engl J Med 2007; 356: 775–89.

215 Abramson MJ, Kaushik S, Benke GP, et al. Symptoms and lung function decline in a middle-aged cohort of males and females in Australia. Int J Chron Obstruct Pulmon Dis 2016; 11: 1097–103.

216 Vestbo J, Agusti A, Wouters EF, et al, and the Evaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints Study Investigators. Should we view chronic obstructive pulmonary disease differently after ECLIPSE? A clinical perspective from the study team. Am J Respir Crit Care Med 2014; 189: 1022–30.

217 O’Byrne PM, Pedersen S, Lamm CJ, Tan WC, Busse WW, and the START Investigators Group. Severe exacerbations and decline in lung function in asthma. Am J Respir Crit Care Med 2009; 179: 19–24.

218 Bonnelykke K, Vissing NH, Sevelsted A, Johnston SL, Bisgaard H. Association between respiratory infections in early life and later asthma is independent of virus type. J Allergy Clin Immunol 2015; 136: 81–86, e4.

219 Jaberolansar N, Toth I, Young PR, Skwarczynski M. Recent advances in the development of subunit-based RSV vaccines. Expert Rev Vaccines 2016; 15: 53–68.

220 Mochizuki H, Kusuda S, Okada K, Yoshihara S, Furuya H, Simoes EA. Palivizumab prophylaxis in preterm infants and subsequent recurrent wheezing: 6 year follow up study. Am J Respir Crit Care Med 2017; published online Feb 2. DOI:10.1164/rccm.201609-1812OC. 221 Nagakumar P, Denney L, Fleming L, Bush A, Lloyd CM, Saglani S. Type 2 innate lymphoid cells in induced sputum from children with severe asthma. J Allergy Clin Immunol 2016; 137: 624–626.

222 Stern DA, Morgan WJ, Halonen M, Wright AL, Martinez FD. Wheezing and bronchial hyper-responsiveness in early childhood as predictors of newly diagnosed asthma in early adulthood: a longitudinal birth-cohort study. Lancet 2008; 372: 1058–64.

223 Johnston IDA, Strachan DP, Anderson HR. Effect of pneumonia and whooping cough in childhood on adult lung function. N Engl J Med 1998; 338: 581–87.

224 Kroner C, Reu S, Teusch V, et al. Genotype alone does not predict the clinical course of SFTPC deficiency in paediatric patients. Eur Respir J 2015; 46: 197–206.

225 Nogee LM, Dunbar AE 3rd, Wert SE, Askin F, Hamvas A, Whitsett JA. A mutation in the surfactant protein C gene associatedwith familial interstitial lung disease. N Engl J Med 2001; 344: 573–79.

226 Schulman SR, Canada AT, Fryer AD, Winsett DW, Costa DL. Airway hyperreactivity produced by short-term exposure to hyperoxia in neonatal guinea pigs. Am J Physiol 1997; 272: L1211–16.

227 Li X, Howard TD, Moore WC, et al. Importance of hedgehog interacting protein and other lung function genes in asthma. J Allergy Clin Immunol 2011; 127: 1457–65.

228 Mason PH. Degeneracy: Demystifying and destigmatizing a core concept in systems biology. Complexity 2015; 20: 12–21.

229 Tieri P, Grignolio A, Zaikin A, et al. Network, degeneracy and bow tie. Integrating paradigms and architectures to grasp the complexity of the immune system. Theor Biol Med Model 2010; 7: 32.

230 Mellen NM. Degeneracy as a substrate for respiratory regulation. Respir Physiol Neurobiol 2010; 172: 1–7.

231 Mayer-Kress G, Liu Y-T, Newell KM. Complex systems and human movement. Complexity 2006; 12: 40–51.

232 Atamas N, Atamas MS, Atamas F, Atamas SP. Non-local competition drives both rapid divergence and prolonged stasis in a model of speciation in populations with degenerate resource consumption. Theor Biol Med Model 2012; 9: 56.

233 Lazic N, Roberts G, Custovic A, et al. Multiple atopy phenotypes and their associations with asthma: similar findings from two birth cohorts. Allergy 2013; 68: 764–70.

234 Belgrave DC, Granell R, Simpson A, et al. Developmental profiles of eczema, wheeze, and rhinitis: two population-based birth cohort studies. PLoS Med 2014; 11: e1001748.

235 Bunyavanich S, Schadt EE. Systems biology of asthma and allergic diseases: a multiscale approach. J Allergy Clin Immunol 2015;135: 31–42.

236 Chen W, Boutaoui N, Brehm JM, et al. ADCYAP1R1 and asthma in Puerto Rican children. Am J Respir Crit Care Med 2013; 187: 584–88.

237 Yang IV, Pedersen BS, Liu A, et al. DNA methylation and childhood asthma in the inner city. J Allergy Clin Immunol 2015; 136: 69–80.

238 Gunawardhana LP, Baines KJ, Mattes J, Murphy VE, Simpson JL, Gibson PG. Differential DNA methylation profiles of infants exposed to maternal asthma during pregnancy. Pediatr Pulmonol 2014; 49: 852–62.

239 Raedler D, Schaub B. Immune mechanisms and development of childhood asthma. Lancet Respir Med 2014; 2: 647–56.

240 Stein MM, Hrusch CL, Gozdz J, et al. Innate immunity and asthma risk in Amish and Hutterite farm children. N Engl J Med 2016; 375: 411–21.

241 Backhed F, Roswall J, Peng Y, et al. Dynamics and Stabilization of the human gut microbiome during the first year of life. Cell Host Microbe 2015; 17: 690–703.

242 Latzin P, Roosli M, Huss A, Kuehni CE, Frey U. Air pollution during pregnancy and lung function in newborns: a birth cohort study. Eur Respir J 2009; 33: 594–603.

243 Kuehni CE, Strippoli MP, Low N, Brooke AM, Silverman M. Wheeze and asthma prevalence and related health-service use in white and south Asian pre-schoolchildren in the United Kingdom. Clin Exp Allergy 2007; 37: 1738–46.

244 von Mutius E. The microbial environment and its influence on asthma prevention in early life. J Allergy Clin Immunol 2016; 137: 680–89.

245 Meyers DA, Bleecker ER, Holloway JW, Holgate ST. Asthma genetics and personalised medicine. Lancet Respir Med 2014; 2: 405–15.

246 Wild CP. The exposome: from concept to utility. Int J Epidemiol 2012; 41: 24–32.

247 Guerra S, Halonen M, Vasquez MM, et al. Relation between circulating CC16 concentrations, lung function, and development of chronic obstructive pulmonary disease across the lifespan: a prospective study. Lancet Respir Med 2015; 3: 613–20.

248 Custovic A, Ainsworth J, Arshad H, et al. The Study Team for Early Life Asthma Research (STELAR) consortium ‘Asthma e-lab’: team science bringing data, methods and investigators together. Thorax 2015; 70: 799–801.

249 Horikoshi M, Beaumont RN, Day FR, et al, and the CHARGE Consortium Hematology Working Group, and the Early Growth Genetics (EGG) Consortium. Genome-wide associations for birth weight and correlations with adult disease. Nature 2016; 538: 248–52.

250 Holt PG, Sly PD, Martinez FD, et al. Drug development strategies for asthma: in search of a new paradigm. Nat Immunol 2004; 5: 695–98.

251 Holt PG, Sly PD. Viral infections and atopy in asthma pathogenesis: new rationales for asthma prevention and treatment. Nat Med 2012; 18: 726–35.

252 Durham SR, Walker SM, Varga E-M, et al. Long-term clinical efficacy of grass-pollen immunotherapy. N Engl J Med 1999; 341: 468–75.

253 Kulus M, Hebert J, Garcia E, Fowler Taylor A, Fernandez Vidaurre C, Blogg M. Omalizumab in children with inadequately controlled severe allergic (IgE-mediated) asthma. Curr Med Res Opin 2010; 26: 1285–93.

254 Busse WW, Morgan WJ, Gergen PJ, et al. Randomized trial of omalizumab (anti-IgE) for asthma in inner-city children. N Engl J Med 2011; 364: 1005–15.

255 Collet JP, Shapiro P, Ernst P, Renzi T, Ducruet T, Robinson A. Effects of an immunostimulating agent on acute exacerbations and hospitalizations in patients with chronic obstructive pulmonary disease. The PARI-IS Study Steering Committee and Research Group. Prevention of acute respiratory infection by an immunostimulant. Am J Respir Crit Care Med 1997; 156: 1719–24.

256 Razi CH, Harmancı K, Abacı A, et al. The immunostimulant OM-85 BV prevents wheezing attacks in preschool children. J Allergy Clin Immunol 2010; 126: 763–69.

257 Devulapalli CS, Carlsen KC, Haland G, et al. Severity of obstructive airways disease by age 2 years predicts asthma at 10 years of age. Thorax 2008; 63: 8–13.

258 Castro-Rodriguez JA, Holberg CJ, Wright AL, Martinez FD. A clinical index to define risk of asthma in young children with recurrent wheezing. Am J Respir Crit Care Med 2000; 162: 1403–06.

259 Klaassen EM, van de Kant KD,  Jobsis Q, et al. Exhaled biomarkers and gene expression at preschool age improve asthma prediction at 6 years of age. Am J Respir Crit Care Med 2015; 191: 201–07.

260 Holt PG, Sly PD, Sampson HA, et al. Prophylactic use of sublingual allergen immunotherapy in high risk children: a pilot study. J Allergy Clin Immunol 2013; 132: 991–93.

261 Du Toit G, Roberts G, Sayre PH, et al, and the LEAP Study Team. Randomized trial of peanut consumption in infants at risk for peanut allergy. N Engl J Med 2015; 372: 803–13.

262 Zolkipli Z, Roberts G, Cornelius V, et al. Randomized controlled trial of primary prevention of atopy using house dust mite allergen oral immunotherapy in early childhood. J Allergy Clin Immunol 2015; 136: 1541–47, e1, 11.

263 Ozdemir O. Various effects of different probiotic strains in allergic disorders: an update from laboratory and clinical data. Clin Exp Immunol 2010; 160: 295–304.

264 Bisgaard H, Stokholm J, Chawes BL, et al. Fish oil-derived fatty acids in pregnancy and wheeze and asthma in offspring. N Engl J Med 2016; 375: 2530–39.

265 Beeh KM, Kanniess F, Wagner F, et al. The novel TLR-9 agonist QbG10 shows clinical efficacy in persistent allergic asthma. J Allergy Clin Immunol 2013; 131: 866–74.

266 Lenney W, Perry S, Price D. Clinical trials and tribulations: the MASCOT study. Thorax 2011; 66: 457–58.

267 Giacoia GP. Incentive to study drugs in children and other governmental initiatives: will patients with asthma benefit? J Allergy Clin Immunol 2000; 106 (suppl 3): S118–24.

268 Reddel HK, Taylor DR, Bateman ED, et al, and the American Thoracic Society/European Respiratory Society Task Force on Asthma Control and Exacerbations. An official American Thoracic Society/European Respiratory Society statement: asthma control and exacerbations: standardizing endpoints for clinical asthma trials and clinical practice. Am J Respir Crit Care Med 2009;180: 59–99.

269 Reddel H, Ware S, Marks G, Salome C, Jenkins C, Woolcock A. Differences between asthma exacerbations and poor asthma control. Lancet 1999; 353: 364–69.

270 Donaldson GC, Wedzicha JA. COPD exacerbations. 1: Epidemiology. Thorax 2006; 61: 164–68.

271 Goss CH, Burns JL. Exacerbations in cystic fibrosis. 1: Epidemiology and pathogenesis. Thorax 2007; 62: 360–67.

272 Blakey JD, Woolnough K, Fellows J, Walker S, Thomas M, Pavord ID. Assessing the risk of attack in the management of asthma: a review and proposal for revision of the current control-centred paradigm. Prim Care Respir J 2013; 22: 344–52.

273 Pizzichini MM, Pizzichini E, Efthimiadis A, et al. Asthma and natural colds. Inflammatory indices in induced sputum: a feasibility study. Am J Respir Crit Care Med 1998; 158: 1178–84.

274 Turner MO, Hussack P, Sears MR, Dolovich J, Hargreave FE. Exacerbations of asthma without sputum eosinophilia. Thorax 1995; 50: 1057–61.